GlassScriptPhysician profile
Jessica Fleischer
NPI 1851464978
$275.34
in general payments reported to CMS, 2019-2025
9 companies · $18.44 in 2025
The $18.44 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $54.15 · 2021: $18.00 · 2024: $62.63 · 2025: $18.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $81.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $81.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $77.77 | 2019-2020 | |
| Medtronic, INC. | $62.63 | 2024 | Minimed 780g |
| Integra Lifesciences Corporation | $28.51 | 2019 | |
| Radius Health, INC. | $27.16 | 2019 | |
| Bioventus LLC | $18.44 | 2025 | Durolane |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Pacira Therapeutics, INC. | $14.77 | 2020 | |
| Endo Pharmaceuticals INC. | $14.16 | 2019 | |
| Amgen INC. | $13.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Fleischer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.